Post Marketing Surveillance of Remicade

Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)

NCT01346826 ·Status: COMPLETED ·Phase: PHASE4

Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

NCT07216014 ·Status: RECRUITING ·Phase: PHASE4

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

NCT00269854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease

NCT06878495 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease

NCT02505568 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

NCT05796245 ·Status: COMPLETED

Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease

NCT02405442 ·Status: TERMINATED ·Phase: PHASE2

Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)

NCT00705614 ·Status: COMPLETED

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

NCT01190839 ·Status: TERMINATED ·Phase: PHASE3

Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease

NCT02054533 ·Status: COMPLETED

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

NCT03452501 ·Status: COMPLETED

"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"

NCT02452151 ·Status: UNKNOWN ·Phase: PHASE4

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy

NCT01181765 ·Status: COMPLETED ·Phase: PHASE4

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

NCT00207662 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

NCT02326155 ·Status: TERMINATED

Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

NCT00055536 ·Status: COMPLETED ·Phase: PHASE2

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease

NCT02539368 ·Status: COMPLETED

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

NCT00207675 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

NCT00036439 ·Status: COMPLETED ·Phase: PHASE3

Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA

Biomarkers to Predict and Monitor Response to Infliximab

NCT04655729 ·Status: UNKNOWN

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

NCT01022749 ·Status: COMPLETED ·Phase: PHASE3

Remicade® Crohn's Disease Registry Across Canada (Study P02793)

NCT00755937 ·Status: TERMINATED

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

NCT01551290 ·Status: COMPLETED ·Phase: PHASE3